Company Filing History:
Years Active: 2026
Title: Jeffrey William Schubert: Innovator in Pain Management
Introduction
Jeffrey William Schubert is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific channel activities in the human body.
Latest Patents
Schubert holds a patent for "2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors." This patent describes novel compounds that serve as inhibitors of Na1.8 channel activity. These compounds may be beneficial in the treatment, prevention, management, amelioration, control, and suppression of diseases mediated by Na1.8 channel activity. Specifically, they may be useful in addressing pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.
Career Highlights
Jeffrey Schubert is associated with Merck Sharp & Dohme LLC, a leading pharmaceutical company. His work focuses on innovative solutions that aim to improve patient outcomes in various medical conditions.
Collaborations
Throughout his career, Schubert has collaborated with esteemed colleagues, including Ashok Arasappan and Ian M Bell. These partnerships have contributed to the advancement of research and development in the pharmaceutical industry.
Conclusion
Jeffrey William Schubert is a prominent inventor whose work in developing NAV1.8 inhibitors showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various disorders, highlighting the importance of innovation in healthcare.